The Canadian Rheumatology Association would like to advise its members of the following reported drug shortage:

Drug Name: Shingrix – Herpes Zoster Vaccine

Expected Resolution of Shortage: December 31, 2018

Provinces Affected: National

Additional Comments: High demand for the drug coupled with the variable timing of supply shipments. Limited supply available of Shingrix 10s.

Status Update:

  • January 18, 2019 Update: High demand for the drug coupled with the variable timing of supply shipments. Re-supply is ongoing with current inventory on allocation.
  • Supply of Shingrix in the 10 dose package size were released on November 26 and are available under allocation – Read more
  • Limited supply of the 1 dose package size is anticipated to be available in mid-December – Read more